Skip to contentI
InspireMD, Inc.
I
NSPRInspireMD, Inc. Q4 2018 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$822.00K$822.00Kderived−1.4% vs Q4 2017 Net Income-$2.21M-$2.21MderivedN/M vs Q4 2017 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
InspireMD, Inc. · CIK 1433607 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$227,000+7.6% Operating Incomederived-$2,206,000N/M Operating Cash Flowderived-$1,803,000N/M Free Cash Flowderived-$1,840,000N/M Margins · derivedGross margin27.6%+2.3 pt vs Q4 2017
Operating margin-268.4%−94.6 pt vs Q4 2017
Net margin-269.2%−89.5 pt vs Q4 2017
ended Dec 31, 2018 · filed Feb 19, 2019 · 50 d after period end